期刊文献+

医院感染多重耐药鲍曼不动杆菌患者死亡危险因素的Meta分析 被引量:28

Meta-analysis on risk factors for death in patients with healthcare-asso-ciated infection caused by multidrug-resistant Acinetobacter baumannii
下载PDF
导出
摘要 目的系统评价医院感染多重耐药鲍曼不动杆菌(MDR-AB)患者死亡危险因素的相关研究,为制定防控策略提供依据。方法计算机检索数据库关于医院感染MDR-AB患者死亡危险因素的病例对照研究,病例组为因医院感染MDR-AB而死亡的患者(死亡组),对照组为医院感染MDR-AB但未死亡的患者(存活组),根据纳入与排除标准各自筛选文献、提取数据和质量评价后,用Rev Man5. 3软件进行Meta分析。结果最终纳入11个研究,共1 204例医院感染MDR-AB患者,其中死亡组474例,存活组730例。Meta分析结果显示:年龄(MD=3. 99)、低蛋白血症(OR=2. 1)、机械通气(OR=4. 23)、气管插管/切开(OR=2. 5)、深静脉置管(OR=2. 21)、移植术后(OR=3. 12)、入院APACHE II评分高(MD=2. 33)是MDR-AB患者死亡的危险因素(均P <0. 05)。结论医院感染MDR-AB患者死亡的危险因素纷繁复杂,需采取针对性的预防措施。 Objective To systematically evaluate the risk factors for death in patients with healthcare -associated infection(HAI) caused by multidrug-resistant Acinetobacter baumannii (MDR-AB),and provide evidence for formulating prevention and control strategies.Methods Case -control studies on risk factors for death in patients with MDR-AB HAI were searched in computer database,patients died of MDR-AB HAI was in death group,those with MDR-AB HAI but survived was in survival group,Meta-analysis was carried out with RevMan 5.3 software after selecting literature,extracting data,and evaluating quality according to inclusion and exclusion criteria.Results A total of 1 204 patients with MDR-AB HAI in 11 studies were enrolled,474 cases were in death group and 730 cases in survival group.Meta-analysis showed that old age ( MD =3.99),hypoproteinemia ( OR =2.1),mechanical ventilation ( OR =4.23),tracheal intubation/tracheotomy ( OR =2.5),deep venous catheterization ( OR =2.21),post-transplantation ( OR =3.12),and high APACHE II score on admission ( MD =2.33) were risk factors for death in MDR-AB patients (all P <0.05).Conclusion Risk factors for death in patients with MDR-AB HAI are complex,corresponding preventive measures should be taken.
作者 陈安林 陈娅 陈泽慧 刘瑶 胡潇云 胡世芸 邱隆敏 CHEN An-lin;CHEN Ya;CHEN Ze -hui;LIU Yao;HU Xiao-yun;HU Shi-yun;QIU Long-min(Department of Clinical Laboratory,Zunyi 563003,China;Department of Infectious Disease,Zunyi 563003,China;Department of Healthcare -associated Infection Management,Zunyi 563003,China)
出处 《中国感染控制杂志》 CAS CSCD 北大核心 2019年第1期53-58,共6页 Chinese Journal of Infection Control
基金 贵州省科技合作计划项目(黔科合LH[2015]7480)
关键词 医院感染 多重耐药 鲍曼不动杆菌 死亡 危险因素 META分析 healthcare -associated infection multidrug-resistance Acinetobacter baumannii death risk factor Meta-analysis
  • 相关文献

参考文献5

二级参考文献71

  • 1李微,殷少军.老年肺炎的临床特点及危险因素研究进展[J].实用老年医学,2013,27(8):691-693. 被引量:18
  • 2Peleg AY, Seifert H, Paterson DLAeinetobaeter baumannii: emergence of a successful pathogen. Clin Micmbiol Rev,2008,21 : 538-582.
  • 3Falagas ME, Koletsi PK, Bliziotis IA.The diversity of definitions of muhidrug-resistant(MDR) and pandrug-resistant (PDR) Aeinetohaeter bsumannli and Pseudomonas aeruginosa.J Med Microbiol, 2006,55: 1619-1629.
  • 4Paterson DL, Doi Y.A step closer to extreme drug resistance(XDR) in gram-negative bacilli.Clin Infect Dis,2007,45: 1179-1181.
  • 5Falagas ME, Karageorgopoulos DE.Pandrug resistance(PDR), extensive drug resistance(XDR), and muhidrug resistance(MDR) among Gram- negative bacilli: need for international harmonization in terminology.Clin Infect Dis, 2008,46: 1121-1122; author reply 1122.
  • 6Zhou H, Yang Q, Yu YS, et al. Clonal Spread of Imipenem-resistant Aeinetobaeter baumannii among different cities of China.J Clin Mierubiol, 2007,45 : 4054-4057.
  • 7Perez F, Hujer AM, Hujer KM, et al.Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 2007,51: 3471-3484.
  • 8Munoz-Price LS, Robert AW.Aclinetobaeter Infection.N Engl J Med,2008,358: 1271-1281.
  • 9Guardado AR, Blanco A, Asensi V, et al.Muhidrug-resistant Aeinetohaeter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother,2008,61 : 908-913.
  • 10Lenie D, Alexandr N, Harald S.An increasing threat in hospitals: multidrug-resistant Aeinetobaeter baumannii.Nat Rev Microbiol, 2007,5: 939-951.

共引文献1079

同被引文献281

引证文献28

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部